Literature DB >> 6958855

The effect of long-term low-dose tetracycline therapy on the subgingival microflora in refractory adult periodontitis.

K S Kornman, E H Karl.   

Abstract

Twenty patients were selected for antibiotic treatment due to poor response to conventional therapy. Ten patients were evaluated after taking 250 mg/day of tetracycline for 2 to 7 years. Ten other patients who had been on tetracycline for at least 2 years were evaluated 6 months to 2 years after stopping the antibiotic. Subgingival plaque was cultured anaerobically on nonselective media (ETSA) and ETSA with 1 microgram/ml of tetracycline HCl. Pocket depth, plaque and gingivitis were scored. Those patients on tetracycline had no bleeding on probing despite residual pockets ranging from 3 to 7 mm. Gram-negative anaerobic rods made up to 49.8% of the microflora of these patients, with Fusobacterium nucleatum dominating. B. melaninogenicus, and B. gingivalis were not detected in the samples. Five of ten patients off tetracycline bled on probing and had pocket depths in the same range as those on tetracycline. The microflora of tetracycline-off sites was predominately Gram-negative rods (63.1% with B. gingivalis and F. nucleatum 7.3% and 3.1% of the flora respectively). In tetracycline-on samples 76.6% of the isolates were resistant to 1 microgram/ml of tetracycline compared to 25.9% in the patients off tetracycline and 7.1% resistant organisms in 14 untreated control samples from periodontitis patients not exposed to any long-term tetracycline therapy. Long-term, low-dose tetracycline was associated with a healthy clinical condition and diverse Gram-negative anaerobic flora resistant to the antibiotic. After discontinuing tetracycline the clinical and bacterial status was more characteristic of disease.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6958855     DOI: 10.1902/jop.1982.53.10.604

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  6 in total

1.  Subinhibitory concentrations of tetracycline alter fibrinogen binding by Bacteroides intermedius.

Authors:  M S Lantz; T Ray; S Krishnasami; D E Pearson
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

2.  Kinetics of drug release from a biodegradable local drug delivery system and its effect on Porphyromonas gingivalis isolates: An in vitro study.

Authors:  Ranganathan Vijayalashmi; Sabitha Manhalore Ravindranath; Nadathur Doraiswamy Jayakumar; Sheeja H Vargheese; Kikkeri Laxminarayana Kumaraswamy
Journal:  J Indian Soc Periodontol       Date:  2013-07

Review 3.  Periodontal therapeutics: Current host-modulation agents and future directions.

Authors:  Lorne M Golub; Hsi-Ming Lee
Journal:  Periodontol 2000       Date:  2020-02       Impact factor: 12.239

4.  Non-antibacterial tetracycline formulations: clinical applications in dentistry and medicine.

Authors:  Ying Gu; Clay Walker; Maria E Ryan; Jeffrey B Payne; Lorne M Golub
Journal:  J Oral Microbiol       Date:  2012-10-12       Impact factor: 5.474

Review 5.  Mechanisms of action of systemic antibiotics used in periodontal treatment and mechanisms of bacterial resistance to these drugs.

Authors:  Geisla Mary Silva Soares; Luciene Cristina Figueiredo; Marcelo Faveri; Sheila Cavalca Cortelli; Poliana Mendes Duarte; Magda Feres
Journal:  J Appl Oral Sci       Date:  2012 May-Jun       Impact factor: 2.698

Review 6.  Historical and contemporary hypotheses on the development of oral diseases: are we there yet?

Authors:  Bob T Rosier; Marko De Jager; Egija Zaura; Bastiaan P Krom
Journal:  Front Cell Infect Microbiol       Date:  2014-07-16       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.